European Society for Medical Oncology Preceptorship on Immuno-Oncology 2023 Zurich

20 $

+ Include: 19 videos + 21 pdfs, size: 2.04 GB

+ Target Audience: oncologist, immunologist

Description

+ Include: 19 videos + 21 pdfs, size: 2.04 GB

+ Target Audience: oncologist, immunologist

+ Sample video: contact me for sample video

+ Information:

Start date: 29 Sep 2023
End date: 30 Sep 2023
Location: Zurich, Switzerland

Learning objectives

  • To understand the basics of tumour immunology
  • To learn about the essentials of immunotherapies and their applications in cancer medicine
  • To learn about the status of development and clinical experience of immunotherapy in different tumour type

 

+ Topics:

ESMO-Preceptorship-on-Immuno-Oncology-2023-Zurich-Programme.pdf
Session 1 Adjuvant vs neoadjuvant.mp4
Session 1 Adjuvant vs neoadjuvant.pdf
Session 1 Basic tumour immunology for oncologists.mp4
Session 1 Basic tumour immunology for oncologists.pdf
Session 1 Biomarkers for immunotherapy.mp4
Session 1 Biomarkers for immunotherapy.pdf
Session 1 Mechanisms of immune resistance.mp4
Session 1 Mechanisms of immune resistance.pdf
Session 2 Immunotherapy for NSCLC.mp4
Session 2 Immunotherapy for NSCLC.pdf
Session 2 Immunotherapy for SCLC and Mesothelioma.mp4
Session 2 Immunotherapy for SCLC and Mesothelioma.pdf
Session 3 Immunotherapy for breast cancer.mp4
Session 3 Immunotherapy for breast cancer.pdf
Session 3 Immunotherapy for gynaecological malignancies.mp4
Session 3 Immunotherapy for gynaecological malignancies.pdf
Session 4 Immunotherapy for gastro-intestinal cancers.mp4
Session 4 Immunotherapy for gastro-intestinal cancers.pdf
Session 5 Developments in adoptive T-cell transfer.mp4
Session 5 Developments in adoptive T-cell transfer.pdf
Session 5 Developments in immune checkpoint inhibition.mp4
Session 5 Developments in immune checkpoint inhibition.pdf
Session 6 Immunotherapy for liver and biliary cancer.mp4
Session 6 Immunotherapy for liver and biliary cancer.pdf
Session 8 IrAEs and management of toxicities.mp4
Session 8 IrAEs and management of toxicities.pdf
Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache.mp4
Session 9 Participant Clinical Case Discussion Autoimmune Flares – A Big Headache.pdf
Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer.mp4
Session 9 Participant Clinical Case Discussion Challenges with Immunotherapy in Hepatocellular Carcinoma and Lung Cancer.pdf
Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do.mp4
Session 9 Participant Clinical Case Discussion First-line Immune Checkpoint Blockade after adjuvant immunotherapy failure? to do or not to do.pdf
Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab.mp4
Session 9 Participant Clinical Case Discussion Immediate and late toxicities from Nivolumab.pdf
Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC.mp4
Session 9 Participant Clinical Case Discussion Immune-related limbic encephalitis in a patient with unresectable locally advanced sqNSCLC.pdf
Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome.mp4
Session 9 Participant Clinical Case Discussion My, oh My, oh My A Case of Myocarditis, Myositis, Myasthenia Overlap Syndrome.pdf
Welcome and Introduction.pdf

Reviews

There are no reviews yet.

Be the first to review “European Society for Medical Oncology Preceptorship on Immuno-Oncology 2023 Zurich”

Your email address will not be published. Required fields are marked *